A Weight-Loss Rival Just Crashed 23%. Why That's Great News for Eli Lilly and Novo Nordisk.
Source: Motley Fool
2026-06-08 12:34:20 ET
The GLP weight-loss space has become increasingly competitive as new players have entered what many believe is a game-changing new market that’s still in the early innings.
But getting in the game is easier said than done.
Shares of the Danish biotech company Zealand Pharma (OTC:ZLDPF) had crashed nearly 23%, as of 12:10 p.m. ET today, after a late-stage study of one of its new weight-loss drugs showed disappointing results.
Zealand Pharma A/S.
NASDAQ: ZLDPF
ZLDPF Trading
2.25% G/L:
$45.50 Last:
284 Volume:
$45.50 Open:
ZLDPF Latest News
July 20, 2026 11:00:00 am
Zealand Pharma: Transactions related to share buy-back program (week 29, 2026)
July 13, 2026 11:00:00 am
Zealand Pharma - Transactions related to share buy-back program (week 28, 2026)
July 06, 2026 11:00:00 am
Zealand Pharma - Transactions related to share buy-back program (week 27, 2026)
June 30, 2026 04:01:00 pm
Total number of shares and voting rights in Zealand Pharma as of June 30, 2026
$4,529,461,750
63,016,002
N/A
117
N/A
Biotechnology & Life Sciences
Healthcare
DK
Soborg
